Abstract:Over 50% of patients who take statins are still at risk of developing atherosclerotic cardiovascular disease (ASCVD) and do not achieve their goal LDL-C levels. This residual risk is largely dependent on triglyceride-rich lipoproteins (TRL) and their remnants. In essence, remnant cholesterol-rich chylomicron (CM) and very-low-density lipoprotein (VLDL) particles play a role in atherogenesis. These remnants increase when lipoprotein lipase (LPL) activity is inhibited. ApoCIII has been thoroughly studied as a chief inhibitor and therapeutic options to curb its effect are available. On top of apoCIII regulation of LPL activity, there is a more precise control of LPL in various tissues, which makes it easier to physiologically divide the TRL burden according to the body's requirements. In general, oxidative tissues such as skeletal and cardiac muscle preferentially take up lipids during fasting. Conversely, LPL activity in adipocytes increases significantly after feeding, while its activity in oxidative tissues decreases concurrently. This perspective addresses the recent improvements in our understanding of circadian LPL regulations and their therapeutic implications. Three major tissue-specific lipolysis regulators have been identified: ANGPTL3, ANGPTL4, and ANGPTL8. Briefly, during the postprandial phase, liver ANGPTL8 acts on ANGPTL3 (which is released continuously from the liver) to inhibit LPL in the heart and muscle through an endocrine mechanism. On the other hand, when fasting, ANGPTL4, which is released by adipocytes, inhibits lipoprotein lipase in adipose tissue in a paracrine manner. ANGPTL3 inhibitors may play a therapeutic role in the treatment of hypertriglyceridemia. Several approaches are under development. We look forward to future studies to clarify (a) the nature of hormonal and nutritional factors that determine ANGPTL3, 4, and 8 activities, along with what long-term impacts may be expected if their regulation is impaired pharmacologically; (b) the understanding of the quantitative hierarchy and interaction of the regulatory actions of apoCIII, apoAV, and ANGPTL on LPL activity; (c) strategies for the safe and proper treatment of postprandial lipemia; and (d) the effect of fructose restriction on ANGPTL3, ANGPTL4, and ANGPTL8.

Lipoprotein Lipase and Its Regulators: an Unfolding Story.

A unified model for regulating lipoprotein lipase activity

Recent advances in physiological lipoprotein metabolism

Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies

1931-P: New Insights into Lipoprotein Lipase Maturation in the ER

8-OR: Novel Mechanism of Lipoprotein Lipase Folding and Maturation in Adipocytes

Research and development of Lipin family

Lipoprotein‐associated phospholipase A2: The story continues

The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding

Regulation of Plasma Lipid Homeostasis by Hepatic Lipoprotein Lipase in Adult Mice.

Lipoprotein lipase and metabolic syndrome

Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins

Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis

Comparative Analyses Of Lipoprotein Lipase, Hepatic Lipase, And Endothelial Lipase, And Their Binding Properties With Known Inhibitors

Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis

The Effect of Phospholipid Transfer Protein on Lipoprotein Metabolism and Atherosclerosis

Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo

The Role of Phospholipid Transfer Protein in the Development of Atherosclerosis

The Role of Endothelial Lipase in Lipid Metabolism, Inflammation, and Cancer.

506-P: Regulation of ANGPTL3 by SEL1L-HRD1 ER-Associated Degradation

Expression of LPL in endothelial-intact artery results in lipid deposition and vascular cell adhesion molecule-1 upregulation in both LPL and ApoE-deficient mice.